AI Terminal

MODULE: AI_ANALYST
Interactive Q&A, Risk Assessment, Summarization
MODULE: DATA_EXTRACT
Excel Export, XBRL Parsing, Table Digitization
MODULE: PEER_COMP
Sector Benchmarking, Sentiment Analysis
SYSTEM ACCESS LOCKED
Authenticate / Register Log In

INTERNATIONAL BIOTECHNOLOGY TST PLC

AGM Information Dec 9, 2024

5163_dva_2024-12-09_1aee2db4-d729-4689-90b1-db63cf798647.html

AGM Information

Open in Viewer

Opens in native device viewer

National Storage Mechanism | Additional information

RNS Number : 4040P

Intl. Biotechnology Trust PLC

09 December 2024

Annual General Meeting

International Biotechnology Trust plc (the "Company") announces that a poll was held on each of the resolutions proposed at the Annual General Meeting ("AGM") on 9 December 2024. The results of the poll are:

Resolution V otes For % Votes Against % Votes Withheld Total Votes Cast (excl. Votes Withheld) % of Issued Share Capital
1 To receive the Annual Report and Financial Statements 8,760,743 87.49% 1,252,909 12.51% 6,308 10,013,652 27.60
2 To approve the Company's dividend policy 10,003,330 99.92% 8,084 0.08% 8,546 10,011,414 27.60
3 To approve the Directors' Remuneration Report 9,931,300 99.40% 59,483 0.60% 29,177 9,990,783 27.54
4 To approve the Directors' Remuneration Policy 9,930,997 99.39% 60,885 0.61% 28,078 9,991,882 27.54
5 To re-elect Gillian

 Elcock
9,963,843 99.65% 35,099 0.35% 21,018 9,998,942 27.56
6 To re-elect Kate Cornish-Bowden 9,966,713 99.68% 32,229 0.32% 21,018 9,998,942 27.56
7 To re-elect Caroline Gulliver 8,716,760 87.18% 1,282,182 12.82% 21,018 9,998,942 27.56
8 To re-elect Patrick

Magee
9,967,138 99.77% 23,135 0.23% 29,687 9,990,273 27.54
9 To re-elect Patrick Maxwell 9,976,368 99.75% 25,405 0.25% 18,187 10,001,773 27.57
10 To re-appoint PricewaterhouseCoopers LLP as auditors 8,710,798 87.10% 1,290,119 12.90% 19,043 10,000,917 27.57
11 To authorise Directors' determination of the auditors' remuneration 9,982,978 99.79% 21,084 0.21% 15,898 10,004,062 27.58
12 To renew the Directors' authority to allot shares 9,980,515 99.70% 30,129 0.30% 9,316 10,010,644 27.59
13* To approve the disapplication of pre-emption rights 9,929,824 99.25% 75,015 0.75% 15,121 10,004,839 27.58
14* To renew the authority to make market purchases of the Company's own shares 9,412,881 94.02% 598,193 5.98% 8,886 10,011,074 27.60
15* To approve the adoption of the new Articles of Association 9,979,295 99.77% 23,469 0.23% 17,196 10,002,764 27.57
16* To approve that a general meeting, other than an annual general meeting, may be called on not less than 14 clear days' notice 9,947,439 99.40% 60,413 0.60% 12,108 10,007,852 27.59

*Resolution 13 to 16 were passed as special resolutions.

Shareholders are entitled to one vote per share. Votes withheld are not a vote in law and are therefore not counted in the calculation of the percentages of the votes cast for and against a resolution. Where shareholders appointed the Chair as their proxy with discretion as to voting, their votes were cast in favour of the resolutions and their shares have been included in the "votes for" column.

The total issued share capital consists of 41,383,817 ordinary shares of £0.25 each, which includes 5,105,511 ordinary shares held in treasury. Treasury shares do not carry voting rights, therefore the total number voting rights in the Company is 36,278,306.

In accordance with UKLR 6.4.2, a copy of the resolutions passed, other than the resolutions concerning ordinary business, at today's AGM will be submitted to the National Storage Mechanism and will be available for inspection at  https://data.fca.org.uk/#/nsm/nationalstoragemechanism .

The proxy votes lodged with the Company's Registrar will shortly be available via the Company's webpages at

International Biotechnology Trust plc - IBT .

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

RAGFSIFWUELSEDE

Talk to a Data Expert

Have a question? We'll get back to you promptly.